KNIGHT THERAPEUTICS INC (GUD.CA) Stock Income Statement
TSX:GUD • CA4990531069
Current stock price
7.54 CAD
+0.08 (+1.07%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 450.09M | 371.30M | 328.20M | 293.56M | 243.48M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | 0.00 | |||
| Cost Of Goods | 242.38M | 193.15M | 172.22M | 155.50M | 128.07M | |||
| Gross Profit | 207.70M | 178.16M | 155.98M | 138.06M | 115.41M | |||
| Operating Expenses | 202.58M | 167.01M | 146.28M | 155.12M | 128.24M | |||
| Research and Development | 28.98M | 23.30M | 17.55M | 14.76M | 12.69M | |||
| Selling, General, and Administrative Expenses | 124.11M | 99.35M | 83.69M | 88.62M | 74.38M | |||
| Operating Income | 5.12M | 11.15M | 9.70M | -17.06M | -12.83M | |||
| Interest Income/Expense | -4.70M | -14.92M | -24.60M | -9.20M | 14.04M | |||
| Other Income/Expense | 349.00K | 9.57M | 2.20M | 4.03M | 5.06M | |||
| Non Recurring Items | -7.47M | -3.75M | -9.29M | -21.72M | 423.00K | |||
| Income Before Taxes | -6.70M | 2.05M | -21.99M | -43.96M | 6.69M | |||
| Income Tax | -1.33M | -2.28M | -5.15M | -14.07M | -8.98M | |||
| Net Income | -5.37M | 4.33M | -16.84M | -29.89M | 15.68M | |||
| EBITDA | 61.69M | 64.26M | 60.10M | 45.56M | 35.08M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.05 | 0.04 | -0.16 | -0.26 | 0.13 | |||
| Non GAAP EPS | -0.04 | 0.05 | -0.16 | -0.26 | 0.12 | |||
| Statistics | ||||||||
| Gross Profit Margin | 46.15% | 47.98% | 47.53% | 47.03% | 47.40% | |||
| Profit Margin | -1.19% | 1.17% | -5.13% | -10.18% | 6.44% | |||
| Operating Profit Margin | 1.14% | 3.00% | 2.96% | -5.81% | -5.27% | |||
All data in CAD